Back to REGN
Carmignac Gestion REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$138.7M
Q3 2026
Peak value
$138.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $38.6M |
| Q1 2026 | $90M |
| Q2 2026 | $113.8M |
| Q3 2026 | $138.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $138.7M | 183.0K | — | — |
| Q2 2026 | $113.8M | 182.5K | — | — |
| Q1 2026 | $90M | 116.6K | — | — |
| Q4 2025 | $38.6M | 50.0K | — | — |